MedTrace Logo

Response of Clostridium Difficile Infection to Metronidazole Therapy

NCT00304369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290

Last updated 2013-02-18

No results posted yet for this study

Summary

In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.

Conditions

  • Clostridium Enterocolitis
  • Pseudomembranous Colitis
  • Antibiotic-Associated Colitis

Interventions

DRUG

Metronidazole

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER

  • Michael E. DeBakey VA Medical Center

    lead FED

Principal Investigators

  • Daniel M Musher, M.D. · Michael E. DeBakey VA Medical Center

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00304369 on ClinicalTrials.gov